References
1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med . 2020;382(8):727-733. doi:10.1056/nejmoa2001017
2. European Centre for Disease Prevention and Control. COVID-19 associated with SARS-CoV-2 Multi-country (World). ECDC . 2020;(December).
3. Chen Z-M, Fu J-F, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr . 2020;16:240-246. doi:10.1007/s12519-020-00345-5
4. European Center for Disease Prevention and Control. COVID-19 in children and the role of school settings in COVID-19 transmission.Ecdc, Stock . 2020;(August):31.
5. Epicentro. Istituto Superiore di Sanità. Sorveglianza integrata COVID-19: i principali dati nazionali.
6. Bellino S, Rota MC, Riccardo F, et al. Pediatric COVID-19 cases prelockdown and postlockdown in Italy. Pediatrics . 2021;147(2). doi:10.1542/peds.2020-035238
7. National COVID-19 Science Task Force N-T. The role of children (≤12 years of age) and adolescents (13-17 years of age) in the SARS-CoV-2 pandemic: A rapid review Questions. 2021.
8. Gaythorpe KAM, Bhatia S, Mangal T, et al. Children’s role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility. Sci Rep . 2021;11(1):1-14. doi:10.1038/s41598-021-92500-9
9. European Centre for Disease Prevention and Control. COVID-19 testing strategies and objectives Key messages. Ecdc, Stock . 2020;(September).
10. Resistance A, Duysburgh ELS, Merckx J, Desombere I. PREVALENCE AND INCIDENCE OF ANTIBODIES AGAINST SARS-COV-2 IN CHILDREN AND SCHOOL STAFF MEASURED BETWEEN DECEMBER 2020 AND JUNE 2021: AN OBSERVATIONAL SERO-PREVALENCE PROSPECTIVE COHORT STUDY. Sciensano . 2021;(June):1-28.
11. Lo Moro G, Sinigaglia T, Bert F, Savatteri A, Gualano MR, Siliquini R. Reopening schools during the COVID-19 pandemic: Overview and rapid systematic review of guidelines and recommendations on preventive measures and the management of cases. Int J Environ Res Public Health . 2020;17(23):1-21. doi:10.3390/ijerph17238839
12. Gruppo di Lavoro ISS M della S, Ministero dell’Istruzione, INAIL FBK, Regione Emilia-Romagna RV. Indicazioni operative per la gestione di casi e focolai di SARS-CoV-2 nelle scuole e nei servizi educativi dell’infanzia. Ist Super di Sanità . 2020.
13. Bert F, Thomas R, Lo Moro G, et al. A new strategy to promote flu vaccination among health care workers: Molinette Hospital’s experience.J Eval Clin Pract . November 2019. doi:10.1111/jep.13295
14. Città della Salute e della Scienza di Torino. A.O.U. Citta della Salute e della Scienza di Torino - Presentazione Regina Margherita.
15. WHO Guidance Note. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases‎‎‎: interim guidance, 11 Setember 2020. World Heal Organ . 2020;(March):20.
16. Cui X, Zhao Z, Zhang T, et al. A Systematic Review and Meta-Analysis of Children with Coronavirus Disease 2019 (COVID-19) . Vol 93. John Wiley & Sons, Ltd; 2021. doi:10.1002/jmv.26398
17. European Centre for Disease Prevention and Control. Contact tracing : P ublic health management of persons , including healthcare workers , having had contact with COVID-19 cases in the European Union Target audience Definition of contact persons Healthcare workers Contact management steps after a case is. ECDE Bull . 2020;(February):7-10.
18. European Centre for Disease Prevention and Control. Contact tracing for COVID-19 : current evidence options for scale-up and an assessment of resources needed. ECDC, Tech Rep . 2020;(April):1-9.
19. Adeyinka A, Bailey K, Pierre L, Kondamudi N. COVID 19 infection: Pediatric perspectives. J Am Coll Emerg Physicians Open . 2021;2(1):1-11. doi:10.1002/emp2.12375
20. Cori A, Ferguson NM, Fraser C, Cauchemez S. A new framework and software to estimate time-varying reproduction numbers during epidemics.Am J Epidemiol . 2013;178(9):1505-1512. doi:10.1093/aje/kwt133
21. Alimohamadi Y, Taghdir M, Sepandi M. Estimate of the basic reproduction number for COVID-19: A systematic review and meta-Analysis.J Prev Med Public Heal . 2020;53(3):151-157. doi:10.3961/JPMPH.20.076
22. Breban R, Vardavas R, Blower S. Theory versus data: How to calculate R0? PLoS One . 2007;2(3):0-3. doi:10.1371/journal.pone.0000282
23. Ministero della Salute. Nuovo coronavirus.
24. Scolastiche I, Visti ILP, Europea U, Piemonte R. Disposizioni attuative per la prevenzione e gestione dell’emergenza epidemiologica da COVID-19. Ordinanza ai sensi dell’art. 32, comma 3, della legge 23 dicembre 1978, n. 833 in materia di igiene e sanità pubblica. Linee di indirizzo per l’organizzazione. Reg Piemonte . 2020.
25. European Centre for Disease Control. COVID-19 in children and the role of school settings in COVID-19 transmission. Ecdc . 2020;(August):31.
26. Viner RM, Mytton OT, Bonell C, et al. Susceptibility to SARS-CoV-2 Infection among Children and Adolescents Compared with Adults: A Systematic Review and Meta-Analysis. JAMA Pediatr . 2021;175(2):143-156. doi:10.1001/jamapediatrics.2020.4573
27. Willeit P, Krause R, Lamprecht B, et al. Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study. Lancet Reg Heal - Eur . 2021;5:1-21. doi:10.1016/j.lanepe.2021.100086
28. Res M, Ruts C, Hospital CR, Sciences M, Committee IE, Crh-smims S. Coronavirus disease 2019 in children: Clinical & epidemiological implications. Indian J Med Res . 2018;(May):517-520. doi:10.4103/ijmr.IJMR
29. Madewell ZJ, Yang Y, Jr IML, Halloran ME, Dean NE. REACT-1 round 7 updated report: regional heterogeneity in changes in prevalence of SARS-CoV-2 infection during the second national COVID-19 lockdown in England. medRxiv . 2020;6(165):1-13.
30. Madewell ZJ, Yang Y, Jr IML, Halloran ME, Dean NE. REACT-1 round 9 final report: Continued but slowing decline of prevalence of SARS-CoV-2 during national lockdown in England in February 2021 Steven.medRxiv . 2020;6(165):1-13.
31. Ecdc. Objectives for COVID-19 testing in school settings - first update, 21 August 2020. Eur Cent Dis Prev Control . 2020;(August):19-22.
32. WHO. Tracking SARS-CoV-2 Variants. WHO.
33. Xia F, Yang X, Cheke RA, Xiao Y. Quantifying competitive advantages of mutant strains in a population involving importation and mass vaccination rollout. Infect Dis Model . 2021;6:988-996. doi:10.1016/j.idm.2021.08.001
34. Centre E. Assessing SARS-CoV-2 circulation , variants of concern , non-pharmaceutical interventions and vaccine rollout in the EU / EEA , 15th update Risk assessed in this update. 2021;(June).
35. Al-Hosani F, Al-Mazrouei S, Al-Memari S, Al-Yafei Z, Paulo MS, Koornneef E. A Review of COVID-19 Mass Testing in the United Arab Emirates. Front Public Heal . 2021;9(May):1-7. doi:10.3389/fpubh.2021.661134
36. Irfan O, Li J, Tang K, Wang Z, Bhutta ZA. Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis. J Glob Health . 2021;11:1-15. doi:10.7189/JOGH.11.05013
37. Yoon Y, Kim KR, Park H, Kim S young, Kim YJ. Stepwise school opening online and off-line and an impact on the epidemiology of COVID-19 in the pediatric population. J Korean Med Sci . 2020;35(46):1-13.